Merck weighs use of COVID antiviral Lagevrio as Ebola outbreak worsens
This story is reported by Fierce Pharma. Read what other outlets are saying below, then open the original report for full details.
This story is reported by Fierce Pharma. Read what other outlets are saying below, then open the original report for full details.